JADBio
JADBio provides a no-code AutoML platform purpose-built for biomedical and life science researchers, enabling biomarker discovery, multi-omics analysis, and survival modeling without data science expertise.
- Company typePrivate
- Founded2013
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What JADBio does
JADBio (legally Gnosis DA S.A., formerly Just Add Data Bio) is a private, bootstrapped software company founded in 2013 and headquartered in Heraklion, Crete, Greece, with a US commercial presence. The company builds an automated machine learning (AutoML) platform purpose-built for biomedical and life science data, specifically engineered to handle the low-sample, high-dimensional datasets typical in genomics, proteomics, transcriptomics, metabolomics, and clinical research. The platform automates the complete machine learning pipeline including data preprocessing, feature selection, hyperparameter tuning, and model selection, and is offered through a no-code GUI for non-expert researchers and a REST API for programmatic integration. Proprietary capabilities include compact feature selection capable of 4000x biomarker reduction without predictive quality loss, survival analysis for time-to-event modeling, and out-of-sample performance estimation with bias correction. The platform is validated through peer-reviewed publications in Nature Precision Oncology and Cell Press's Cancer Cell.
JADBio firmographics
Firmographics- Name
- JADBio
- Legal name
- Gnosis DA S.A.
- Website
- https://jadbio.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- JADBio provides a no-code AutoML platform purpose-built for biomedical and life science researchers, enabling biomarker discovery, multi-omics analysis, and survival modeling without data science expertise.
- Ownership category
- akta.pro rank
JADBio industry classification
Industry- Product category
- Biomedical Analytics Software
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), AutoML & Low-Code ML Platform Operations (HDAAABAL), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where JADBio is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
JADBio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Subscription (AutoML Platform): Cloud-based AutoML platform delivered as SaaS subscription, with tiered pricing tiers including Basic (free), and paid plans for professional and enterprise use.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free Basic Plan |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
JADBio product offering
Product offeringCore offering
JADBio provides an automated machine learning (AutoML) platform purpose-built for low-sample, high-dimensional biomedical and life-science data. The platform automates the full ML pipeline—data preprocessing, feature selection, hyperparameter tuning, and model selection—to enable biomarker discovery, survival analysis, and predictive modeling on multi-omics data (genomics, transcriptomics, proteomics, metabolomics, clinical data and images). It is delivered via a no-code GUI for life scientists and a REST API for developers, with availability through AWS Marketplace.
Product overview
JADBio (Just Add Data Bio) offers an automated machine learning platform specifically designed for biomedical and life science data. The product portfolio consists of two main offerings: the JADBio GUI, a no-code AutoML platform for non-expert users to perform predictive modeling and biomarker discovery through a web interface, and the JADBio API, a REST API that provides programmatic access to the same AutoML capabilities for developers integrating ML into their applications. The platform is purpose-built for multi-omics data including Genomics, Transcriptome, Metagenome, Proteome, Metabolome, and Clinical Data, and specializes in low-sample, high-dimensional datasets typical in biomedical research.
Differentiator
Problem solved
Functional benefit
Products and services
- JADBio GUI A no-code AutoML platform that enables life scientists and bioinformaticians to perform automated machine learning analysis on biomedical and multi-omics data without programming expertise. Provides point-and-click access to predictive modeling, feature selection, biomarker discovery, and survival analysis. Targeted at academic and industry researchers who need ML capabilities without dedicated data science staff.
- JADBio API REST API providing programmatic access to JADBio's AutoML platform, enabling developers and data scientists to integrate automated machine learning, feature selection, predictive modeling, and survival analysis into their own applications and workflows. Designed for low-sample, high-dimensional biomedical datasets including multi-omics data.
Quantifiable outcome
- Up to 4000x reduction in biomarkers to consider without drop in predictive quality against state-of-the-art
- +3 more outcomes
Companies that use JADBio
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
JADBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
JADBio partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Black Arrow BiotechcoreBlack Arrow Biotech is integrating JADBio's advanced AI technology into its proprietary peptide screening platform to accelerate peptide drug discovery. This partnership combines Black Arrow's screening capabilities with JADBio's AutoML for enhanced discovery workflows.
- DiamiR BiosciencescoreDiamiR Biosciences partnered with JADBio to utilize machine learning in assay development. DiamiR develops innovative diagnostic solutions for neurological disorders and is leveraging JADBio's AutoML platform for enhanced assay development capabilities.
- QIAGENminorQIAGEN partners with JADBio for event presence and distribution. JADBio appears at QIAGEN's booth at industry conferences such as BioData World Congress for networking and lead generation.
- FilgenminorFilgen is a Japanese biotechnology company and partner for distribution and research collaboration in the Japanese market.
- Amazon Web Services (AWS)coreJADBio's AutoML platform is available in the AWS Marketplace, enabling cloud-based access and procurement through AWS. The partnership leverages AWS infrastructure for platform delivery.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
JADBio competitors and assessment
Company assessmentBroad incumbents
- DataRobot: Enterprise AutoML platform serving multiple verticals including life sciences. Directly comparable on AutoML core capability but broader and general-purpose, lacking JADBio's deep multi-omics specialization.
- H2O.ai: General-purpose AutoML and MLOps platform with some healthcare/life sciences customers. Comparable as an AutoML alternative but does not match JADBio's purpose-built biomedical feature selection.
- Google Vertex AI: Hyperscaler AutoML offering with broad enterprise reach. Competes for the same AutoML-for-biomedical workloads from a general-purpose cloud platform angle, with vastly greater scale.
- Schrödinger: Computational drug discovery platform combining physics-based modeling with ML. Comparable as a software-and-AI vendor to life sciences R&D, though anchored in molecular simulation rather than biomarker AutoML.
Direct peers
- Insitro: AI-driven drug discovery company combining ML with proprietary data and wet-lab experimentation. Comparable in applying ML to life sciences, though vertically integrated into drug programs rather than selling the ML tool itself.
- Owkin: AI-for-biopharma platform focused on multi-modal biomedical data and federated learning for drug discovery and diagnostics. Directly comparable on multi-omics/clinical data ML for life sciences.
- CytoReason: AI platform for cell-level disease modeling and multi-omics data in drug discovery. Comparable as a domain-specialized ML platform serving biopharma R&D customers with multi-omics inputs.
Emerging players
- Dotmatics: Scientific R&D informatics platform for life sciences with ML-augmented analysis. Comparable as a software layer for biomedical researchers, though broader in scope (ELN, LIMS, analytics).
- Benchling: Cloud platform for life sciences R&D with growing ML/biologics capabilities. Comparable as a research informatics platform serving biologists, with overlapping buyers though different primary use cases.
- Elucidata: Multi-omics data platform with ML-ready pipelines for biomedical researchers. Comparable as an existing partner and as an adjacent platform serving the same multi-omics + biomarker discovery workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
JADBio social profiles
Digital presenceJADBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
JADBio leadership team
Management profileNumber of profiles
Profiles5 records
JADBio funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JADBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JADBio
What does JADBio do?
JADBio provides an automated machine learning (AutoML) platform purpose-built for low-sample, high-dimensional biomedical and life-science data. The platform automates the full ML pipeline—data preprocessing, feature selection, hyperparameter tuning, and model selection—to enable biomarker discovery, survival analysis, and predictive modeling on multi-omics data (genomics, transcriptomics, proteomics, metabolomics, clinical data and images). It is delivered via a no-code GUI for life scientists and a REST API for developers, with availability through AWS Marketplace.
Is JADBio a public or private company?
JADBio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was JADBio founded?
JADBio was founded in 2013. It employs 11 to 50 people.
Where is JADBio based?
JADBio is headquartered in Los Angeles, United States, in the North America region.
How does JADBio make money?
One revenue line is on record: saaS Subscription (AutoML Platform).
Who are JADBio's main competitors?
Broad incumbents on record are DataRobot, H2O.ai, Google Vertex AI and Schrödinger. Direct peers are Insitro, Owkin and CytoReason. Emerging players are Dotmatics, Benchling and Elucidata.
Does JADBio have an API?
Yes. JADBio AutoML REST API that provides programmatic access to the AutoML platform, enabling developers to build and automate predictive models, feature selection, and survival analysis directly from their applications. The platform is specifically designed for low-sample, high-dimensional biomedical datasets including multi-omics data. Developer documentation is at support.jadbio.com.
What industry is JADBio in?
JADBio's product category is Biomedical Analytics Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 541511 and its SIC code is 8731.